$3.89
2.14%
NYSE, Sep 25, 04:01 pm EDT. Closed.
ISIN
US78574H1041
Symbol
SOC

Sable Offshore Stock News

Neutral
●
Business Wire
●
about 2 months ago
HOUSTON--(BUSINESS WIRE)--Sable Offshore Corp. Reports Second Quarter 2026 Financial and Operational Results.
Neutral
●
Business Wire
●
3 months ago
HOUSTON--(BUSINESS WIRE)--Sable Offshore Corp. Prices Offerings of Common Stock and Convertible Senior Notes.
Neutral
●
Business Wire
●
3 months ago
HOUSTON--(BUSINESS WIRE)--Sable Offshore Corp. Announces Proposed Offerings of Common Stock and Convertible Senior Notes.
Neutral
●
GlobeNewsWire
●
3 months ago
ALLENTOWN, Pa., June 24, 2026 (GLOBE NEWSWIRE) -- CAI, a global services firm, was awarded a statewide contract with the Virginia Information Technologies Agency (VITA) to provide Security Operations Center (SOC) services to local government entities across the Commonwealth.
Neutral
●
GlobeNewsWire
●
3 months ago
WILMINGTON, Del., June 23, 2026 (GLOBE NEWSWIRE) -- Quavo, Inc. ("Quavo"), the leading AI disputes technology partner and strategic advisor for financial institutions and technology companies, today announced the completion of its first System and Organization Controls (SOC) 1 Type 1 examination.
Neutral
●
Business Wire
●
3 months ago
NEW YORK--(BUSINESS WIRE)--Hack The Box (HTB), the global leader in AI cybersecurity readiness, today announced new capabilities to help security leaders gain greater visibility into skills, performance and operational readiness. As AI transforms cyberattacks and cybersecurity operations, HTB is expanding its cyber readiness platform to help organizations identify gaps, evaluate team performanc...
Neutral
●
Business Wire
●
3 months ago
HOUSTON--(BUSINESS WIRE)--Sable Offshore Corp. Enters Into Senior Secured Term Loan Amendment and Limited Waiver Under the PSA.
Neutral
●
GlobeNewsWire
●
3 months ago
MANCHESTER, United Kingdom and OSAKA, Japan, June 18, 2026 (GLOBE NEWSWIRE) -- F2G Ltd and Shionogi & Co., Ltd (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D) (“Shionogi”) today announced positive topline results from the global Phase 3 OASIS study (NCT05101187), comparing the investigational oral antifungal drug olorofim versus AmBisome® (liposomal amphotericin B for...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today